A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer - Eguchi, K; Etou, H; Miyachi, S; Morinari, H; Nakada, K; Noda, K; Ohkuni, Y; Watanabe, K; Yamada, Y; Ohe, Y; Tamura, T; Sasaki, Y; Shonkai, T; Saijo, N (Eur J Cancer, 1994)